Purpose of review Food allergy is common among children and adults worldwide. Recent studies have improved our understanding of the genetic mechanism of food allergy and further studies may result in clinical application through genetic testing.
INTRODUCTION
Food allergy is a type of adverse immune response where exposure to certain food(s) induces allergy rather than tolerance. The food allergens are diverse, with cow's milk, egg, peanut, tree nut, soy, wheat, fish, and shellfish being most common, especially in children. The overall prevalence of food allergy has been increasing and is around 8% in children and 5% in adults [1] . To date, no known medication prevents food allergy and strict avoidance remains the main treatment [2] .
Genetic factors play an important role in the development of food allergy and are one of the major risk factors for its development. Family and twin studies show that family history is an important risk factor for food allergy, which imposes a two to 10-fold increased risk [3] [4] [5] [6] or 15-80% higher incidence, depending on the study setting, population, method of measurement of allergy, and food allergen [5, 7, 8] .
The genetic mechanism underlying development of food allergy and its interplay with environmental factors are a burning research topic. In this review, we will discuss recent discoveries from candidate gene studies, unbiased genome-wide approaches to findings from epigenetic and gut microbiome studies.
] includes studies where positive associations were found between commonly studied candidate genes and food allergy. It is important to be aware that many of these associations have neither been extensively tested in other populations nor been replicated and inconsistent results exist for some variants/genes, thus many associations remain inconclusive.
The human leukocyte antigen (HLA) plays major roles in immune regulation. Therefore, it is not surprising that the HLA genetic locus has been highly significantly associated with multiple immune disorders, including allergic diseases [26] [27] [28] . A positive association between HLA and food allergy was reported in 1997 [9] and since then many HLA loci have been implicated [10, 11, 29] . A recent study [12] in a relatively large Canadian pediatric cohort illustrated a significant association of HLA-DQB1 Ã 02 and DQB1 Ã 06 : 03P with peanut allergy. However, the drawback of this study is the low genotyping call rate [12,13 && ]. Another candidate locus for food allergy, now examined in multiple populations, is the filaggrin (FLG) gene which interacts with keratin filaments.
FLG is important for the skin barrier and mutations in FLG have been found to be associated with severe eczema [30] and FLG loss-of-function (FLG-LOF) mutations have been associated with peanut allergy [14, 15] . A recent longitudinal study in the United Kingdom examined the association between the total effect of FLG-LOF mutations and all-cause food allergy at different ages in 1150 children. Significant association was observed at ages 10 and 18 years [17] . Association of FLG mutations with food allergy has also been shown in populations of the Netherlands and Denmark [16, 18] . In addition to these LOF mutations, common variants in gene FLG have also been reported to be associated with food allergy. A study in a Japanese population found a common variant rs1933064 in FLG to be associated with food allergy sensitization. The variant might affect promoter activity and thus skin barrier function [19] . A separate study [31] also showed that exposure to peanut antigen in household dust in early life increases the risk of developing peanut sensitization and allergy for children having FLG-LOF mutations. Despite the large body of evidence for FLG association with food allergy, new study [32] also suggests that FLG mutations are not significantly associated with food sensitization among adults without atopic dermatitis. Thus, the relationship between FLG mutations/variants, food allergy, and potential confounding factor atopic dermatitis needs to be further evaluated.
Interleukins are a large class of genes that play crucial roles in immune responses and have been related to allergic disease. IL-10 has been mostly investigated for its potential association with food allergy. The cytokine IL-10 is generated mainly from monocytes, but also lymphocytes, in response to commensal or pathogenic flora. IL-10 plays pleiotropic regulatory roles such as suppressing the level of major histocompatibility complex class II antigens and Th1 cytokines, inhibiting nuclear factor kappa-lightchain-enhancer of activated B cells (NF-kB) singling and promoting B-cell proliferation and antibody production, which influences the balance between Th1 and Th2 responses [33, 34] . Older studies [20, 35, 36] have not presented convincing evidence supporting an association with food allergy, because of caveats in analytical methods, such as lacking of multiple testing adjustments. A more recent study in Brazilian children examined several IL-10 polymorphisms and a variant in the Transforming Growth Factor b1 gene (TGFb1). The only significant association found was that of IL-10 polymorphism -1082G/A with cow's milk allergy (CMA) [21] .
The JAK-STAT (Janus kinase -Signal Transducer and Activator of Transcription) signaling pathway serves many important functions in the immune
KEY POINTS
Results from candidate gene studies suggest that genetic variants in several genes, including the HLA locus, IL-10, STAT6, FOXP3, and FLG, are associated with food allergy; however, inconsistent results were found in different populations.
The only GWAS of food allergy identified genomewide significant association at the HLA-DR and DQ regions, and demonstrated that this association is partially mediated by differential DNA methylation.
The only CNV study of food allergy using genome-wide SNP array identified association of CNVs impacting the CTNNA3 and RBFOX1 genes in study participants with food allergy.
Epigenetic studies implicate DNA methylation effects impacting genes in the mitogen-activated protein kinases pathway, as well as IL-4, IL-5, IL-10, INF-g all of which are associated with food allergy. Recent studies also revealed the differences in the gut microbiota between food allergy patients and healthy controls.
Further research dissecting the genetic underpinnings and the interplay between genetic components and diverse environmental factors will hopefully lead to the development of a panel of reliable biomarkers for the genetic testing of food allergy. [37] . Previous studies have demonstrated an association between polymorphisms in STAT6 and nut allergy [22] . Furthermore, single nucleotide polymorphisms (SNPs) close to STAT6 (within 20 kb upstream/ downstream of STAT6 transcript) have been associated with food allergen sensitization found as a secondary phenotype from a genome-wide association study (GWAS) [23] . In addition, the GG genotype of STAT6 polymorphism rs324015 showed a nominally significant association with longer persistence of CMA than the AA þ AG genotype states. In that study [38] , variants of other candidate genes CD14, IL-10, IL-13, SPINK5, and Thymic Stromal Lymphopoietin (TSLP) did not demonstrate such an association. As T cells play key roles in food allergy responses, genes with functions in T-cell maturation, activation, and differentiation present candidate genes for food allergy. In this regard, forkhead box P3 (FOXP3) encodes a transcription factor of the forkhead/ winged-helix family that is critical for the normal function of regulatory T cells [39] . Defects in FOXP3 are associated with immune diseases such as immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) and an older study [24] found an association between a deletion in the 5' region of FOXP3 and a subtype of IPEX patients showing multiple food allergies. A more recent study [40] found significantly lower levels of FOXP3 mRNA expression among children with asthma and food allergy compared with healthy controls.
Taken together, while candidate gene studies have tried to explore the underlying genetic factors for food allergy for decades, very few firm associations have been established. Several reasons could explain why the studies yielded such inconsistent results. How the outcome variable, food allergy, is measured and defined is not consistent across studies. Many of the studies are underpowered because of limited sample size, suffered from diverse study populations and/or confounding issues because of population stratification. Also some studies did not adjust for multiple testing. Furthermore, food allergy is highly subjected to environment impact and many of these candidate gene studies have different environmental exposure patterns that are not being controlled for.
COMMON VARIANTS AND COPY NUMBER VARIATIONS DISCOVERED BY UNBIASED GENOME-WIDE APPROACHES
As an unbiased approach to detect susceptibility loci for complex diseases, GWAS have undergone rapid development and yielded numerous successful discoveries that replicate consistently even across different ethnic groups. In GWAS, the association between the genotype of common variants (minor allele frequency >5%) and disease status are examined across the genome. So far, only one published study focuses specifically on food allergy; in this study, Hong et al. [13 && ] reported that HLA-DR and DQ regions at locus 6p21.32 are significantly associated with peanut allergy (top SNPs: rs7192, P ¼ 5.5 Â 10
À8
; rs9275596, P ¼ 6.8 Â 10 À10 ) in a cohort of 2197 US study participants of European ancestry ( Table 1 ). The association was replicated in an independent cohort of 62 peanut allergy cases and 69 controls of European ancestry. The results are in line with previous studies suggesting the important role of HLA in allergic diseases and suggestive associations from previous candidate gene studies of food allergy [13 && ]. Copy number variation (CNV) is another type of genetic variant associated with susceptibility for multiple diseases, especially psychiatric diseases [41, 42] . To date, only a single, very recent study [25 & ] has examined the association of CNV with food allergy. In this study, a significant association was found between food allergy and CNVs in gene CTNNA3 using genome-wide SNP array analysis in both a pediatric discovery cohort (357 cases, 3980 controls) and a replication cohort (167 children with food allergy, 1573 controls) ( Table 1) . Additional significant association was found in gene RBFOX1 in the subset of participants of European ancestry (Table 1 ). In addition, more prominent expression upregulation of CD63 and CD203c following phorbol myristate acetate stimulation was observed in mononuclear cells treated with CTNNA3 small interfering RNA compared with controls, implicating that CTNNA3 is involved in sensitization to allergen [25 & ].
RARE VARIANTS IDENTIFICATION WITH SEQUENCING TECHNOLOGY
Apart from common variant association with complex diseases, rare variants could also contribute to the cause of complex diseases, including allergic diseases and in some cases may have a large effect. DeWan and colleagues reported cosegregation of rare coding variants in the genes Phosphodiesterase 4D Interacting Protein (PDE4DIP), Casitas B-Lineage Lymphoma Proto-Oncogene B (CBLB), and Kalirin RhoGEF Kinase (KALRN) with an asthma phenotype. This was a family-based study [43] using whole-exome sequencing; however, functional studies are lacking to evaluate the roles of these variants in disease cause. Another study [44] of sequencing candidate genes found an association with asthma and rare variants in or at the flanking regions of Dipeptidyl-Peptidase 10 (DPP10), Interleukin 12 Receptor Beta 1 (IL-12RB1), IkappaB Kinase Complex-Associated Protein (IKBKAP), and Angiotensinogen (AGT) in either EuropeanAmericans or African-Americans. There has been no report of rare variants associated with food allergy via targeted sequencing, whole-exome sequencing, or whole-genome sequencing. However, with the advance of sequencing technology, analytical tools, and reduced cost, we anticipate that this will change soon, especially for identification of underlying variants in severe and familial cases.
FINDINGS FROM EPIGENETIC STUDIES
Similar to other complex diseases, the development of food allergy is shaped by host factors, environmental factors, and the interactions between those. Differential DNA methylation is an epigenetics mechanism that reflects environmental effects upon the human genome. It has been shown that during T-cell differentiation, epigenetic modification plays a critical role, highlighting its relevance to the development of food allergy [45, 46] . A few studies have attempted to assess the role of DNA methylation in food allergy.
By using an epigenome-wide association analysis, Martino et al. compared the DNA methylation profile of CD4 þ T cells between 12 children with IgE-mediated food allergy and 12 healthy controls at birth and 12 months of age. A group of 92 probes were identified as differentially methylated from case-control analyses at both time points, and to be non-SNP associated. Pathway enrichment analysis of the genes that these probes are mapped to yielded the nominally significant association of mitogen-activated protein kinases (MAPK) signaling pathway (P ¼ 0.042) and food allergy. Four genes in this pathway contain differentially methylated probes. Fifteen probes at three genes were further validated by mass spectrometry, and the expression level of some genes was correlated with differential methylation [47 & ]. In a study examining the effect of oral immunotherapy on peanut allergy, Syed and colleagues [48] observed the correlation of low methylation level of FOXP3 CpG sites with immune tolerant status. When comparing overall promoter methylation level of cytokine genes IL-4, IL-5, IL-10, and INF-g, Berni Canani and colleagues observed that the methylation level of these genes were significantly different between children with active IgEmediated CMA, those who outgrew CMA and healthy controls. Methylation levels were lowest within the active CMA group and the highest amongst healthy controls for both IL-4 and IL-5, with the opposite pattern being seen for IL-10 and INF-g. The expression level of these genes correlates with their methylation levels [49] . In the GWAS study of food allergy by Hong and colleagues, the authors also examined the potential epigenetic contribution. They demonstrated a significant correlation between the two top-associated SNPs and CpG sites' methylation levels in the genes HLA-DQB1 and HLA-DRB1, and furthermore, showed that the SNP association with the phenotype is partially mediated by the differential methylation [13 && ].
UNDERSTANDING OF THE GUT MICROBIOTA
In addition to the genetic makeup of the host, the gut microbiota composition likely plays an important role, based on epidemiology studies of allergic diseases and mouse models [50] . Two large cross-sectional studies [51, 52] of more than 14 000 and 79 000 children previously showed and recently confirmed that farm exposure is associated with reduced prevalence of allergic disease and atopy. Multiple other studies [53] [54] [55] , including those directly assessing the gut microbiota composition using 16S rDNA analysis, have demonstrated the inverse correlation between gut microbiota diversity and the risk of developing allergic diseases. Several studies [56] [57] [58] using mouse models have shown that alterations in gut microbiota constitution affect allergen sensitization. The underlying mechanisms include impact on intestinal barrier function through IL-22 signaling and Toll-like receptors [57, [59] [60] [61] .
Very few studies have specifically explored the association between intestinal microbiota and food allergy. Recently, Ling and colleagues revealed that the proportion of several important gut bacterial phylotypes showed significant changes among food allergy patients compared with healthy controls by targeted parallel pyrosequencing of the 16S rRNA gene. Furthermore, differences also exist between IgE-mediated food allergy and non-IgE-mediated food allergy. Ling Z. et al. also demonstrated a negative correlation between host IL-10 level and food allergy-enriched phylotypes. This study [62] was conducted among Chinese participants. A new Canadian study [63] examined the abundance and diversity of gut microbiota by illumina 16S rRNA sequencing and found the risk of developing food allergen sensitization to be inversely correlated with microbiota richness and positively associated with the ratio of Enterobacteriaceae/ Bacteroidaceae. The inverse correlation between food sensitization and diversity of gut microbiota was similarly observed in a study in Taiwan [64] . However, these studies are of small sample sizes and lack of replication, and therefore the results need to be interpreted with caution. The gut microbiota composition is affected by various environmental factors, like diet and exposure to pets [65, 66] . Further studies need to assess how host genetic factors interact with gut microbiota and environmental factors, which is an important yet complicated aspect in predicting the risk of developing food allergy and in establishing reliable genetic testing for food allergy.
FUTURE GENETIC TESTING
Genetic testing evaluates for underlying mutations/ variants that are causal or relevant to the diseases in question. The general purpose of genetic testing includes several aspects, such as disease diagnosis, identifying causal mutations, predicting disease progression and prognosis, predicting responses to medication/treatment, and identification of populations at risk for early prevention. Genetic testing is now applied in the clinic for many diseases, for example, to test for mutations in breast cancer type 1 susceptibility protein (BRCA1) and breast cancer type 2 susceptibility protein (BRCA2) for breast and ovarian cancers, checking for mutations in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) for cystic fibrosis and checking the hemoglobin A gene for sickle cell mutations. A reliable genetic test should provide reliable and relevant information regarding development of the disease in question. As discussed above, though underlying genetic mechanism for food allergy are starting to unravel, a panel of reliable markers for genetic testing in food allergy is still lacking. The future possibilities of such testing lies in further research dissecting the complex interplay between genetic components and diverse environmental factors, including the microbiota, in the pathogenesis and expression of food allergy. In the near future, we anticipate to establish a panel of biomarkers to identify high-risk populations where preventive measures can reduce severe food allergy emergencies, facilitate accurate identification of allergen sources, and to predict effective treatment options, and thus improve overall patient care.
CONCLUSION
The development of food allergy is shaped by both genetic components and environmental factors. Through candidate gene studies, GWAS, and CNV studies, we have begun to dissect the genetic mechanisms underlying food allergy. However, because of the limitation of sample sizes, population differences, and phenotype heterogeneity, many results are inconsistent and more studies are needed to validate the discoveries, as well as to identify contributions from additional genetic variants, such as rare variants. The interactions between genetic components and environmental factors constitute another important aspect to explore. Important topics in this regard include, but are not limited to, epigenetic effects and gut microbiota. Gaining a better understanding of the genetic and environmental impact of food allergy will allow us to develop a clinically applicable biomarker panel for genetic testing, which will be of benefit in diagnosis, therapeutics, and even prevention of food allergya prototype precision medicine focus.
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